2006 News Releases

Dec 8, 2006 Patent "Use Of Tetrodotoxin and Saxitoxin and Their Analogs In Manufacturing Analgesic Drugs For Systemic Analgesia" Granted By SIPO
Dec 7, 2006 Chief Financial Officer Resigns
Dec 5, 2006 Pre-CTA Meeting With Health Canada
Dec 1, 2006 WEX Concluded More Flexible Repayment Terms With Debenture Holders
Nov 25, 2006 WEX Announces Private Placement
Nov 15, 2006 WEX Reports Second Quarter Results
Oct 5, 2006 WEX Announces Option Exercise Price Reduction and Grant of Stock Options
Sept 29, 2006 Wex Announces Results of Shareholders Meeting
Sept 20, 2006 WEX Announces Legal Proceedings Against Tianjin Fairwood
Sept 11, 2006 President's Message
Sept 7, 2006 Annual and Special Shareholders Meeting Update
Sept 6, 2006 WEX Announces the Continuation of Tetrodotoxin Development for Cancer-related Pain
Aug 29, 2006 WEX Announces Its Rights Offering
Aug 28, 2006 Two Patents Issued
Aug 24, 2006 Meeting with BGTD of Health Canada
Aug 21, 2006 Private Placement
Aug 14, 2006 First Quarter Financial Results
Aug 11, 2006 Shareholders' Meeting Update
Aug 10, 2006 Collaboration with Children's Hospital Boston
Aug 04, 2006 Shareholders' Meeting Rescheduled
Jul 28, 2006 Continuation of TTX Development and Esteve Collaboration
Jul 06, 2006 Preliminary Results of Detailed Analysis
Jun 30, 2006 Vice President Resigns
Jun 29, 2006 Year End Financial Results
Jun 12, 2006 FDA Approves New Drug Application
May 01, 2006 Corporate Update
Apr 25, 2006 Appointment of Chief Financial Officer
Mar 27, 2006 Manufacturing Inspection Report
Mar 17, 2006 Corporate Restructuring
Mar 08, 2006 Dr. Euan Taylor Steps Down
Mar 05, 2006 Tectin™ Phase IIB/III Interim Analysis
Feb 16, 2006 Reports Third Quarter Results
Feb 14, 2006 To Release Third Quarter Results
Feb 10, 2006 New General Manager of Hong Kong
Jan 27, 2006 Special Shareholder Meeting Update
Jan 24, 2006 Resignation from the Board of Directors
Jan 13, 2006 Notice of Change of Venue for Special Meeting

< 2005 news :: 2007news >